Ascorbate
US-FDASourced from openFDA
GET
/api/v1/drug/ascorbateWarnings & precautions
Sourced from openFDAAllergen Warning Contains fish gelatin and soy oil.
Approval history
Sourced from openFDA- Aug 2, 2006NDANDA021881Salix Pharms
- Jan 25, 2012ANDAANDA090145Novel Labs Inc
- May 4, 2018NDANDA209381Salix
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
3,173 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Vomiting58418%
- 2Nausea46215%
- 3Drug Ineffective2688.4%
- 4Diarrhoea2176.8%
- 5Dehydration1875.9%
- 6Abdominal Pain1825.7%
- 7Headache1765.5%
- 8Malaise1554.9%
- 9Dizziness1434.5%
- 10Product Taste Abnormal1414.4%
- 11Dyspnoea1364.3%
- 12Pyrexia1304.1%
- 13Asthenia1264.0%
- 14Hyponatraemia1253.9%
- 15Fatigue1233.9%
Clinical trials
The 10 most recently updated of 113 ClinicalTrials.gov registrations naming Ascorbate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid CancerNot yet recruiting · Phase 1 · Phase 2 · Interventional · 18 enrolled · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT06991738updated 2026-06-12
- High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell DisordersRecruiting · Phase 1 · Interventional · 18 enrolled · University of ArkansasNCT06313502updated 2026-06-04
- The Body's Affect on Vitamin CCompleted · Phase 1 · Interventional · 23 enrolled · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00001309updated 2026-06-01
- Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)Active not recruiting · Early phase 1 · Interventional · 30 enrolled · University of IowaNCT04634227updated 2026-05-22
- Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon CleansingCompleted · Phase 4 · Interventional · 1,180 enrolled · Parc de Salut MarNCT04598880updated 2026-05-14
- Vitamin C 4 Care HomesWithdrawn · Interventional · 0 enrolled · University of AberdeenNCT05122481updated 2026-05-05
- Impact of Chewing Gum on Bowel Preparation in Patients Undergoing ColonoscopyActive not recruiting · Interventional · 100 enrolled · University of Maryland, BaltimoreNCT07320989updated 2026-04-17
- The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent ClaudicationActive not recruiting · Phase 1 · Interventional · 10 enrolled · Louis MessinaNCT04800692updated 2026-04-15
- High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)Recruiting · Phase 1 · Interventional · 30 enrolled · Kittika PoonsombudlertNCT07177079updated 2026-04-09
- A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLCActive not recruiting · Phase 2 · Interventional · 43 enrolled · Joseph J. Cullen, MD, FACSNCT02905591updated 2026-03-25
Note. Data for
ascorbate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.